Open access
Aug 2026
CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity
Evans et al. identify CD1d as a key regulator of myeloid cell diversity in breast cancer. CD1d targeting reshapes tumor immune infiltrates, suppresses tumor growth, and enhances immunotherapy efficacy, suggesting an actionable pathway for therapeutic intervention.
Lauren Evans, Maria Conde Poole, Cenk Celik et al.
· Journal of Experimental Medi... · 0 citations